Valuation: Provexis plc

Market Cap 18.88M 24.97M 22.63M 20.93M 35.59M 2.35B 36.84M 251M 99.7M 1.26B 93.71M 91.72M 3.99B P/E 2025
-22.6x
P/E 2026 -50.2x
Enterprise Value 17.99M 23.79M 21.56M 19.94M 33.9M 2.24B 35.1M 240M 94.98M 1.2B 89.28M 87.38M 3.8B EV / Sales 2025
7.62x
EV / Sales 2026 19.2x
Free-Float
78.89%
Yield 2025 *
-
Yield 2026 -
1 week-5.85%
Current month+0.62%
1 month-21.84%
3 months-27.80%
6 months-21.08%
Current year-10.56%
1 week 0.71
Extreme 0.71
0.97
1 month 0.71
Extreme 0.71
1.1
Current year 0.71
Extreme 0.71
1.55
1 year 0.56
Extreme 0.555
1.55
3 years 0.4
Extreme 0.4
1.55
5 years 0.4
Extreme 0.4
1.55
10 years 0.2
Extreme 0.2
1.55
Manager TitleAgeSince
Chief Executive Officer 61 -
Chief Tech/Sci/R&D Officer 53 01/01/2000
Director TitleAgeSince
Director/Board Member 61 11/11/2010
Chairman 80 01/06/2005
Director/Board Member 53 12/04/2019
Date Insider Type Main position Quantity % Market Cap. Importance
7/1/25 Free

Chief Executive Officer

30,000,000 1.2788%
24/1/23 Free

Chief Executive Officer

17,000,000 0.7665%
24/1/23 Free

Chief Technology Officer

17,000,000 0.7665%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-5.85%+40.00%+45.83% 24.99M
+1.33%+0.56%+7.43%-11.73% 267B
+1.25%+1.87%+18.05%-2.95% 84.25B
+1.31%+1.81%-12.02%+21.67% 49.01B
+0.58%-2.45%-2.48%-10.78% 34.83B
+2.49%+3.87%+23.54%-0.49% 33.78B
+0.61%-2.13%-9.28%-9.05% 29.62B
+2.39%+2.22%+11.45%+15.33% 29.37B
+2.72%+1.97%+0.54%-24.50% 28.98B
+0.12%+0.84%-0.94%+4.13% 25.91B
Average +1.40%-0.70%+7.63%+2.75% 58B
Weighted average by Cap. +1.94%-0.43%+6.31%-5.37%

Financials

2025 2026
Net sales 1.29M 1.71M 1.55M 1.43M 2.44M 161M 2.52M 17.21M 6.82M 86.06M 6.41M 6.28M 273M 1.26M 1.67M 1.52M 1.4M 2.38M 158M 2.47M 16.84M 6.68M 84.22M 6.27M 6.14M 267M
Net income -453K -599K -542K -502K -853K -56.44M -883K -6.03M -2.39M -30.15M -2.25M -2.2M -95.71M -503K -665K -602K -557K -947K -62.68M -981K -6.69M -2.65M -33.48M -2.49M -2.44M -106M
Net Debt -708K -936K -848K -785K -1.33M -88.28M -1.38M -9.43M -3.74M -47.16M -3.51M -3.44M -150M -893K -1.18M -1.07M -990K -1.68M -111M -1.74M -11.89M -4.72M -59.48M -4.43M -4.34M -189M
Projected Income Statement - Annual - Provexis plc
Logo Provexis plc
Provexis plc is a United Kingdom-based company that develops, licenses and sells the proprietary, scientifically proven Fruitflow heart-health functional food ingredient. Fruitflow is a natural extract from tomatoes which has been shown in human trials to reduce the propensity for aberrant blood clotting, typically associated with cardiovascular disease, which can lead to heart attack and stroke. The extract is available as a spray-dried powder, and it can be included in a broad range of food, beverage and dietary supplement formats. Fruittflow is a highly concentrated form of bioactives which is lycopene-free and contains over 30 known antiplatelet compounds. The Company also offers Fruitflow+, Omega-3, and dietary supplement products which are sold directly to consumers. In addition, the Company supplies Fruitflow as an ingredient to brand owners in the food, beverage, and supplement sectors through DSM Nutritional Products’ distribution network.
Employees
2
Date Price Change Volume
14/11/26 GBX 0.8050 0.00% 1,009,122
12/11/26 GBX 0.8050 -5.85% 437,738
11/11/26 GBX 0.8550 0.00% 3,028
10/11/26 GBX 0.8550 0.00% 5,001
09/11/26 GBX 0.8550 0.00% 476,654